DE2700178A1 - Verfahren zur herstellung von 1,3-disubstituiertem-2-acetidinon - Google Patents

Verfahren zur herstellung von 1,3-disubstituiertem-2-acetidinon

Info

Publication number
DE2700178A1
DE2700178A1 DE19772700178 DE2700178A DE2700178A1 DE 2700178 A1 DE2700178 A1 DE 2700178A1 DE 19772700178 DE19772700178 DE 19772700178 DE 2700178 A DE2700178 A DE 2700178A DE 2700178 A1 DE2700178 A1 DE 2700178A1
Authority
DE
Germany
Prior art keywords
mixture
acid
ester
compound
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772700178
Other languages
German (de)
English (en)
Inventor
Masashi Hashimoto
Takashi Kamiya
Osamu Nakaguti
Yoshiharu Nakai
Teruo Okum
Hidekazu Takeno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE2700178A1 publication Critical patent/DE2700178A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/04Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19772700178 1976-01-05 1977-01-04 Verfahren zur herstellung von 1,3-disubstituiertem-2-acetidinon Withdrawn DE2700178A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24276 1976-01-05

Publications (1)

Publication Number Publication Date
DE2700178A1 true DE2700178A1 (de) 1977-07-14

Family

ID=9700935

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772700178 Withdrawn DE2700178A1 (de) 1976-01-05 1977-01-04 Verfahren zur herstellung von 1,3-disubstituiertem-2-acetidinon

Country Status (4)

Country Link
JP (1) JPS52106857A (enrdf_load_stackoverflow)
BE (1) BE850085A (enrdf_load_stackoverflow)
DE (1) DE2700178A1 (enrdf_load_stackoverflow)
FR (1) FR2357543A1 (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190786A1 (en) * 1985-02-08 1986-08-13 Shell Internationale Researchmaatschappij B.V. Azetidine derivatives; process for their preparation; and their use as intermediates
EP0146900A3 (en) * 1983-12-27 1988-03-30 Takeda Chemical Industries, Ltd. Process for producing azetidinones
AT389695B (de) * 1981-10-23 1990-01-10 Roussel Uclaf Verfahren zur herstellung von neuen 3-amino-2-oxo-azetidin-1-sulfonderivaten

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Chem. Soc. Perkin I, 1975, S.1880-1884 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389695B (de) * 1981-10-23 1990-01-10 Roussel Uclaf Verfahren zur herstellung von neuen 3-amino-2-oxo-azetidin-1-sulfonderivaten
EP0146900A3 (en) * 1983-12-27 1988-03-30 Takeda Chemical Industries, Ltd. Process for producing azetidinones
EP0190786A1 (en) * 1985-02-08 1986-08-13 Shell Internationale Researchmaatschappij B.V. Azetidine derivatives; process for their preparation; and their use as intermediates

Also Published As

Publication number Publication date
FR2357543B1 (enrdf_load_stackoverflow) 1979-08-24
JPS613785B2 (enrdf_load_stackoverflow) 1986-02-04
FR2357543A1 (fr) 1978-02-03
JPS52106857A (en) 1977-09-07
BE850085A (fr) 1977-07-04

Similar Documents

Publication Publication Date Title
DE3148021A1 (de) 1-sulfo-2-oxoazetidin-derivate, ihre herstellung und ihre verwendung
EP0042026A1 (de) 3,4-Disubstituierte Azetidin-2-onverbindungen und Verfahren zu ihrer Herstellung
DE3851749T2 (de) Verfahren zur Herstellung von 3-hydrocarbyl-3-cephemverbindungen.
DE2529941A1 (de) Azetidinonderivate und verfahren zu ihrer herstellung
CH630073A5 (de) Verfahren zur herstellung von 2-azetidinonverbindungen.
JPS63152388A (ja) 新規なセフェム化合物
DE2151567A1 (de) 8-Oxo-5-thia-1-azabicyclo[4,2,0]oct-2-en-Verbindungen
DD287495A5 (de) Verfahren zur herstellung herterozyclischer stickstoffverbindungen
DE2223667C2 (de) Verfahren zur Herstellung von 8-Oxo-5-thia-1-azabicyclo-[4,2,0]oct-2-en- oder -3-en-Verbindungen
DE2700178A1 (de) Verfahren zur herstellung von 1,3-disubstituiertem-2-acetidinon
EP0000500B1 (de) Cephalosporinderivate, Verfahren zu deren Herstellung und deren pharmazeutische Präparate
DE4019960C2 (de) Neue Penamderivate und deren Salze, Verfahren zu ihrer Herstellung und antibakterielles Mittel mit einem Gehalt derselben
DE2914060A1 (de) Cephalosporinderivate, ihre herstellung und verwendung
DE2736482A1 (de) Salze von derivaten von 6-(1-sulfato-aethyl)-7-oxo-1-azabicyclo eckige klammer auf 3.2.0 eckige klammer zu hept-2-en-2-carbonsaeureestern, verfahren zu ihrer herstellung und diese salze enthaltende arzneipraeparate
CH647524A5 (de) 7alpha-methoxycephalosporine und verfahren zur herstellung derselben.
CH618440A5 (enrdf_load_stackoverflow)
DE2501638A1 (de) Verfahren zur epimerisierung von penicillinverbindungen
CH671765A5 (enrdf_load_stackoverflow)
CH621351A5 (enrdf_load_stackoverflow)
CH618161A5 (en) Process for the preparation of azetidinone derivatives
DE2437143A1 (de) Substituierte phenylglycylcephalosporine, ihre salze, verfahren zu ihrer herstellung und arzneimittel
DE2818985C2 (de) Halogenarylmalonamidooxacephalosporine und deren Verwendung bei der Bekämpfung bakterieller Infektionen
DE2539214A1 (de) 7-methoxythienyl- und -furyl-ureido- cephalosporine
AT331411B (de) Verfahren zur herstellung von neuen 2,3-niedrigalkylenpenam-3-carbonsaurederivaten
CH642350A5 (en) Process for the preparation of 2-azetidinone compounds

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: TUERK, D., DIPL.-CHEM. DR.RER.NAT. GILLE, C., DIPL

8139 Disposal/non-payment of the annual fee